Crafting concise and authoritative healthcare resources

Discover how S. Karger has positioned itself as a reference in the healthcare industry by publishing trusted content for 30 years.

RSV Vaccine 90% Effective in High-Risk Adults, Real-World Study Shows

The bivalent RSV prefusion F vaccine (Abrysvo) demonstrated 90% vaccine effectiveness (VE) in high-risk adults against hospitalizations or emergency department (ED) visits associated with respiratory

October 31, 2024

Their first baby came with medical debt. These Illinois parents won’t have another.

Heather Crivilare was a month from her due date when she was rushed to an operating room for an emergency cesarean section.

May 10, 2024

Lilly backs OrsoBio’s $60M Series A for PhII trials in obesity and NASH

OrsoBio, a biotech focused on obesity and metabolic disorders, is getting financial support from one of the leading drugmakers in the field as Eli Lilly

November 8, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.